Page Text: Andrew Stone , (Apr 14, 2022)
Post pandemic, pharma and regulators are both working to accelerate the transformative power of electronic filing
Andrew Stone , (Mar 10, 2022)
The FDA is developing guidelines that will help pharma accelerate its adoption of RWE, this is what the industry should know
Brian Eastwood , (Jan 6, 2022)
The FDA and other regulatory bodies are increasingly willing to accept real-world evidence as part of approvals. Pharma is up to the task
Katie Osborne , (Sep 24, 2021)
Convincing payers of the value of digital add-ons and of drug/device combinations requires pharma to demonstrate that patients and other stakeholders understand how to use them
Lucy Fulford , (Jul 6, 2021)
Patient real-world data contains a wealth of potentially valuable information for life sciences commercial teams, if they can filter out the noise